Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Consolidation Expected to Increase for Hospitals, IT Companies

June 30, 2014

Report predicts spike in deal activity following decline in 2013

Nashville, Tenn., (June 30, 2014) – Hospitals and healthcare providers, as well as healthcare IT companies, are the subsectors most likely to see increased consolidation in 2014-2015, according to a report published today by Bass, Berry & Sims PLC.

Published in association with Mergermarket, the "Healthcare & Life Sciences M&A Outlook" cites capital needs and economies of scale as the two major drivers for consolidation among hospitals and providers.

"This year we're seeing significant implications from the Affordable Care Act take hold," said Angela Humphreys, a Member of the firm and healthcare transactions attorney. "Reforms like these are pushing providers to do more, better, for less – which in turn drives them to consolidate to become stronger in this new healthcare climate."

Deal activity took a downward turn in 2013, dropping to 385 deals worth $97 billion from 459 deals worth $124 billion in 2012, according to Mergermarket data. 

"Last year's decline was due to uncertainty around implementation of the ACA – much of which has been clarified," said Leigh Walton, a Member of the firm and healthcare transactions attorney member of the firm's healthcare and corporate practices. "We now have a clearer picture of how the law will affect healthcare organizations.

"As the reimbursement and regulatory landscapes change dramatically, healthcare companies are jockeying to be better positioned to leverage capital resources and a stronger infrastructure."

Overall, 86 percent of respondents expect M&A activity to increase in healthcare and life sciences. Specifically, respondents pointed to these top strategic drivers: 

  • Increased demand for facility and equipment improvement – 46 percent
  • Need for IT support/capabilities – 42 percent
  • Rising compliance costs – 42 percent

Respondents believe private equity will be most interested in the hospital and biotechnology/pharmaceutical sectors, with 42 percent of respondents choosing each as their top choice.

The "Healthcare & Life Sciences M&A Outlook" is based on interviews with healthcare and life sciences professionals. View the full report here.

About the Healthcare Practice of Bass, Berry & Sims
Marked by an integrated approach and unmatched regulatory experience, the healthcare practice of Bass, Berry & Sims PLC is a team of more than 100 experienced attorneys who leverage their diverse strengths to meet the unique demands of our clients. Throughout our history, Bass, Berry & Sims has contributed to the evolution of Nashville as the nation’s capital of healthcare delivery and entrepreneurialism. From this experience, we know that issues impacting healthcare organizations require a multidisciplinary team informed by historical perspective. For more information, visit www.bassberry.com or follow us on Twitter: @BassBerryHealth.

About Mergermarket
Mergermarket is the leading provider of forward-looking M&A news and intelligence for M&A professionals and corporates. With an unrivalled network of 300+ journalists based in 65 locations worldwide, Mergermarket is the only specialized media service that offers active analysis of corporate strategy before it becomes public knowledge, and a historical deals database to analyze past deals. Mergermarket is part of The Mergermarket Group, a Financial Times Group company. For more information visit www.mergermarket.com or follow us on Twitter: @mergermarket.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.